| Previous close | 6.74 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 238,464 |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.73 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
EQS-News: Vita 34 AG / Key word(s): Quarter ResultsVita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment 31.05.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment First quarter sales up 15.7 percent to EUR 17.9 million Gross profit benefits from price adjustments and cost discipline and increas
EQS-News: Vita 34 AG / Key word(s): StudyVita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate 12.05.2023 / 09:10 CET/CESTThe issuer is solely responsible for the content of this announcement.Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate Approval by responsible authorities and ethics committee granted Recruitment of the first patient imminent Completion of Phase I expected by the end of 2023Leipzig, 12 May 2023 - Vita 34 AG (ISIN: DE000A0BL849; WKN: A0
EQS-News: Vita 34 AG / Key word(s): Annual ResultsDevelopment of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects 30.04.2023 / 12:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects Group revenue of EUR 68.9 million 142.6 percent above previous year after merger with PBKM FamiCord (Guidance: EUR 65 to 72 mil
Vita 34 AG / Key word(s): ForecastVita 34 AG publishes outlook for the 2023 financial year25-Apr-2023 / 18:43 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Vita 34 AG publishes outlook for the 2023 financial yearLeipzig, April 25, 2023 - In the context of the preparation of the consolidated financial statements 2022, th
Vita 34 AG / Key word(s): Preliminary Results2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill06-Apr-2023 / 20:39 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.2022 annual result of Vita 34 AG significantly influenced by impairment of goodwillLeipzig, 6 April 2023 - As part of the 2022
EQS-News: Vita 34 AG / Key word(s): 9 Month figuresVita 34 benefits from increasing normalization in its core business in the third quarter 22.11.2022 / 15:51 CET/CESTThe issuer is solely responsible for the content of this announcement.Vita 34 benefits from increasing normalization in its core business in the third quarter Revenues for the first nine months rose to EUR 50.8 million; business development gains further momentum in the third quarter EBITDA of EUR -1.6 million in the first nine mon
DGAP-News: Vita 34 AG / Key word(s): Half Year Results/Half Year ReportVita 34 records moderate upward trend in the second quarter 30.08.2022 / 19:20 CET/CESTThe issuer is solely responsible for the content of this announcement.Vita 34 records moderate upward trend in the second quarter- Revenues in the first half of the year show significant increase to EUR 32.1 million due to fully consolidated results coming from business combination with PBKM FamiCord - As expected, EBITDA of EUR -2.6 millio
Vita 34 AG / Key word(s): ForecastVita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures29-Aug-2022 / 23:25 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures Leipzig, 29 August
DGAP-News: Vita 34 AG / Key word(s): AGM/EGMVita 34 introduces new Chief Financial Officer at the Annual General Meeting 29.06.2022 / 13:22 The issuer is solely responsible for the content of this announcement.Vita 34 introduces new Chief Financial Officer at the Annual General Meeting Dirk Plaga presented as new Chief Financial Officer of the Group with effect from 1 August Interim CFO Andreas Schafhirt continues to support post-merger integration as advisor High level of approval for all items